7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 
      
    		                       
      operating activities
    		                       
      net earnings
    		455,000,000 633,000,000 437,000,000 2,569,000,000                    
      discontinued operations, net of tax
    		-21,000,000   -2,599,000,000                    
      adjustments for non-cash items, net:
    		                       
      depreciation and amortization
    		325,000,000 317,000,000 303,000,000 318,000,000 289,000,000 311,000,000 314,000,000 135,000,000 134,000,000 137,000,000 136,000,000 123,000,000 102,000,000 76,000,000 79,000,000 87,000,000 83,000,000 85,000,000 83,000,000 95,000,000 82,000,000 78,000,000 81,000,000 
      deferred income tax provision
    		-158,000,000 -89,000,000 -69,000,000 -56,000,000 42,000,000 -215,000,000 -123,000,000 -82,000,000 -41,000,000 -86,000,000 -24,000,000 -17,000,000 -90,000,000 -65,000,000 48,000,000 -143,000,000 36,000,000 35,000,000 -2,000,000 -24,000,000 -14,000,000 0 135,000,000 
      stock-based compensation costs
    		11,000,000 21,000,000 23,000,000  17,000,000 26,000,000 22,000,000  23,000,000 18,000,000 22,000,000  17,000,000 20,000,000 21,000,000  20,000,000 21,000,000 19,000,000     
      equity method investment net earnings
    		-60,000,000 -78,000,000 -44,000,000 -44,000,000 -66,000,000 -90,000,000 -31,000,000 -40,000,000 -75,000,000 -52,000,000 -44,000,000 -40,000,000 -63,000,000 -101,000,000 -58,000,000 -48,000,000 -76,000,000 -87,000,000 -38,000,000 -59,000,000 -62,000,000 -57,000,000 -29,000,000 
      (gain) loss on extinguishment of debt
    		   6,000,000        0 0 0 -36,000,000         
      (gain) loss on sale of investments
    		0          -16,000,000 29,000,000 -725,000,000 -7,000,000 -1,112,000,000         
      changes in operating assets and liabilities
    		                       
      accounts receivable
    		212,000,000 -340,000,000 -362,000,000 95,000,000 151,000,000 -81,000,000 -205,000,000 149,000,000 109,000,000 -249,000,000 -157,000,000 288,000,000 50,000,000 -276,000,000 -207,000,000 193,000,000 -2,000,000 -205,000,000 -83,000,000 166,000,000 -144,000,000 46,000,000 -19,000,000 
      inventories
    		-116,000,000 -111,000,000 -301,000,000 216,000,000 78,000,000 70,000,000 -72,000,000 230,000,000 66,000,000 67,000,000 -126,000,000 158,000,000 -57,000,000 -45,000,000 -390,000,000 -64,000,000 -134,000,000 38,000,000 -248,000,000 -3,000,000 88,000,000 -61,000,000 -264,000,000 
      accounts payable and accrued liabilities
    		-208,000,000 -103,000,000 481,000,000 345,000,000 -1,376,000,000 1,313,000,000 -195,000,000 -14,000,000 371,000,000 145,000,000 -25,000,000 -119,000,000 101,000,000 -53,000,000 132,000,000 333,000,000 128,000,000 217,000,000 151,000,000 -292,000,000 377,000,000 176,000,000 -24,000,000 
      distributions from equity method investments
    		24,000,000 4,000,000 77,000,000 10,000,000 24,000,000 5,000,000 7,000,000 84,000,000 35,000,000 7,000,000 3,000,000 93,000,000 40,000,000 4,000,000 11,000,000 94,000,000 23,000,000 30,000,000 12,000,000 81,000,000 39,000,000 39,000,000 10,000,000 
      other operating activities
    		-140,000,000 5,000,000 -52,000,000 -198,000,000   143,000,000 15,000,000 28,000,000 -39,000,000 -6,000,000 65,000,000 38,000,000 -43,000,000 83,000,000 73,000,000 42,000,000 -69,000,000 -50,000,000 146,000,000 9,000,000 71,000,000 -6,000,000 
      net cash flows from continuing operating activities
    		324,000,000 264,000,000 488,000,000 363,000,000                    
      net cash flows from discontinued operating activities
    		17,000,000 385,000,000 -5,000,000 -231,000,000                    
      net cash flows from operating activities
    		341,000,000 649,000,000 483,000,000 132,000,000 -269,000,000 660,000,000 40,000,000 1,062,000,000 1,041,000,000 384,000,000 120,000,000 1,123,000,000 790,000,000 32,000,000 -202,000,000 913,000,000 579,000,000 561,000,000 184,000,000 199,000,000 937,000,000 509,000,000 47,000,000 
      investing activities
    		                       
      capital expenditures
    		-117,000,000 -81,000,000 -63,000,000 -217,000,000 -87,000,000 -111,000,000 -104,000,000 -233,000,000 -92,000,000 -74,000,000 -70,000,000 -140,000,000 -91,000,000 -66,000,000 -56,000,000 -138,000,000 -74,000,000 -79,000,000 -53,000,000 -161,000,000 -57,000,000 -46,000,000 -48,000,000 
      free cash flows
    		224,000,000 568,000,000 420,000,000 -85,000,000 -356,000,000 549,000,000 -64,000,000 829,000,000 949,000,000 310,000,000 50,000,000 983,000,000 699,000,000 -34,000,000 -258,000,000 775,000,000 505,000,000 482,000,000 131,000,000 38,000,000 880,000,000 463,000,000 -1,000,000 
      investment in businesses, net of cash acquired
    		-31,000,000 -49,000,000 -12,000,000 -17,000,000 -94,000,000 -7,000,000 -10,772,000,000 -15,000,000 -13,000,000 -4,000,000 -52,000,000 -34,000,000 -434,000,000 -29,000,000 -9,000,000 -152,000,000 -47,000,000 -161,000,000 -6,000,000     
      dispositions of businesses
    		0 0 8,000,000     0 18,000,000 1,000,000 35,000,000 -42,000,000 0 9,000,000 2,935,000,000  2,000,000       
      settlement of derivative contracts
    		33,000,000 51,000,000 36,000,000 -77,000,000 -2,000,000 24,000,000 -209,000,000 16,000,000 -52,000,000 4,000,000 -18,000,000 8,000,000 -79,000,000 -91,000,000 -32,000,000 22,000,000 -12,000,000 -14,000,000 8,000,000     
      other investing activities
    		-4,000,000 -4,000,000 1,000,000 -17,000,000 2,000,000 25,000,000 4,000,000 3,000,000 4,000,000 11,000,000 5,000,000  4,000,000 2,000,000 -18,000,000 -2,000,000 6,000,000 1,000,000 2,000,000 -13,000,000 0 94,000,000 -80,000,000 
      net cash flows from continuing investing activities
    		-119,000,000 -83,000,000 -30,000,000 306,000,000                    
      net cash flows from discontinued investing activities
    		0 28,000,000 7,000,000 2,783,000,000                    
      net cash flows from investing activities
    		-119,000,000 -55,000,000 -23,000,000 3,089,000,000 1,159,000,000 4,808,000,000 -11,081,000,000 -229,000,000 -135,000,000 -196,000,000 -100,000,000 -300,000,000 -600,000,000 -175,000,000 2,820,000,000 -266,000,000 -125,000,000 -252,000,000 -49,000,000 876,000,000    
      financing activities
    		                       
      increase in short-term borrowings
    		444,000,000 -8,000,000 -49,000,000 13,000,000   19,000,000 20,000,000 -16,000,000 -29,000,000 10,000,000 -15,000,000 -103,000,000 11,000,000 -33,000,000 30,000,000 -4,000,000 -41,000,000 28,000,000 -1,000,000 -5,000,000 27,000,000 -44,000,000 
      issuance of long-term debt
    		17,000,000 6,000,000 9,000,000 826,000,000 31,000,000 7,000,000 2,548,000,000 5,595,000,000 8,000,000 1,000,000 5,000,000 11,000,000 400,000,000 7,000,000 14,000,000 18,000,000 48,000,000 23,000,000 51,000,000 22,000,000 28,000,000 773,000,000 10,961,000,000 
      repayment of long-term debt
    		-1,000,000 -3,000,000 -1,205,000,000 -815,000,000 -988,000,000 -3,537,000,000 -5,000,000 -96,000,000 -3,000,000 -10,000,000 -2,000,000 -90,000,000 -58,000,000 -4,000,000 -1,123,000,000 -12,000,000 -87,000,000 -35,000,000 -570,000,000 -1,787,000,000 -88,000,000 -2,000,000 -34,000,000 
      repurchases of common stock
    		-785,000,000 -340,000,000 -1,288,000,000 -1,513,000,000    0 0 0 -62,000,000 -119,000,000 -247,000,000 -280,000,000 -734,000,000 -252,000,000 -145,000,000 -94,000,000 -36,000,000     
      dividends paid on common stock
    		-193,000,000 -192,000,000 -198,000,000 -156,000,000 -184,000,000 -171,000,000 -159,000,000 -155,000,000 -156,000,000 -155,000,000 -154,000,000 -125,000,000 -127,000,000 -128,000,000 -129,000,000 -104,000,000 -104,000,000 -105,000,000 -104,000,000 -68,000,000    
      dividends paid to non-controlling interest
    		-72,000,000   -12,000,000 -5,000,000 -65,000,000 -2,000,000 -12,000,000 -5,000,000   -24,000,000 0   -10,000,000 -2,000,000 -25,000,000 -5,000,000 -31,000,000 -9,000,000 0 -8,000,000 
      other financing activities
    		-1,000,000 -1,000,000 -16,000,000 -15,000,000 7,000,000 0 -22,000,000 -52,000,000 -10,000,000 -59,000,000 -10,000,000 15,000,000 -15,000,000 2,000,000 -15,000,000 -7,000,000 -33,000,000 22,000,000 -7,000,000 11,000,000 2,000,000 4,000,000 -3,000,000 
      net cash flows from continuing financing activities
    		-591,000,000 -547,000,000 -2,747,000,000 -1,672,000,000                    
      net cash flows from discontinued financing activities
    		   -14,000,000                    
      net cash flows from financing activities
    		-591,000,000 -547,000,000 -2,747,000,000 -1,686,000,000 -1,544,000,000 -3,785,000,000 2,379,000,000 5,300,000,000 -182,000,000 -293,000,000 -213,000,000 -347,000,000 -150,000,000 -414,000,000 -2,020,000,000 -337,000,000 -327,000,000 -255,000,000 -643,000,000  -142,000,000   
      effect of foreign exchange rate changes on cash and cash equivalents
    		-5,000,000 51,000,000 17,000,000 -85,000,000 64,000,000 -14,000,000 -68,000,000 133,000,000 -32,000,000 -33,000,000 20,000,000 59,000,000 -74,000,000 -40,000,000 -1,000,000 -1,000,000 -13,000,000 7,000,000 -9,000,000   11,000,000 -28,000,000 
      net increase in cash and cash equivalents and restricted cash, including cash classified in current assets held for sale
    		-374,000,000 98,000,000 -2,270,000,000 1,450,000,000 -590,000,000 1,669,000,000 -8,730,000,000                 
      less: change in cash balances classified as assets held for sale
    		   -284,000,000 -70,000,000 64,000,000 -30,000,000         -14,000,000        
      net increase in cash and cash equivalents and restricted cash
    		-374,000,000 98,000,000 -2,270,000,000 1,734,000,000 -520,000,000 1,605,000,000 -8,700,000,000 6,109,000,000 692,000,000 -138,000,000 -173,000,000 535,000,000   597,000,000 249,000,000 114,000,000 61,000,000 -517,000,000 -734,000,000 1,145,000,000   
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 3,972,000,000 -1,000,000 -163,000,000 0 10,017,000,000 0 0 0 3,527,000,000 1,000,000 0 0 3,025,000,000 -1,000,000 0 0 3,120,000,000 0 0 0 957,000,000 
      cash, cash equivalents and restricted cash, end of period
    		-374,000,000 98,000,000 1,702,000,000 1,733,000,000 -683,000,000 1,605,000,000 1,317,000,000 6,109,000,000 692,000,000 -138,000,000 3,354,000,000 536,000,000 -34,000,000 -597,000,000 3,622,000,000 322,000,000 40,000,000 61,000,000 2,603,000,000 -734,000,000 1,145,000,000 1,936,000,000 772,000,000 
      less: restricted cash
    		0 -1,000,000 4,000,000 -11,000,000 11,000,000 -1,000,000 4,000,000 -4,000,000 -1,000,000 0 7,000,000 1,000,000 -2,000,000 -10,000,000 18,000,000 6,000,000 -1,000,000 30,000,000 4,000,000 -1,000,000 1,000,000 0 4,000,000 
      cash and cash equivalents, end of period
    		-374,000,000 99,000,000 1,698,000,000 1,744,000,000 -694,000,000 1,606,000,000 1,313,000,000 6,113,000,000 693,000,000 -138,000,000 3,347,000,000 535,000,000 -32,000,000 -587,000,000 3,604,000,000 316,000,000 41,000,000 31,000,000 2,599,000,000 -733,000,000 1,144,000,000 1,936,000,000 768,000,000 
      (gain) loss on sale of investments / deconsolidation
    		  -5,000,000 -320,000,000 2,879,000,000   0 2,000,000               
      stock-based compensation cost
    		                       
      payment to former shareholders of tcc
    		                       
      customer relationships
    		                       
      patents and trademarks
    		                       
      monitoring lines
    		                       
      service portfolio and other
    		                       
      net income from operations
    		     2,369,000,000 289,000,000 439,000,000 381,000,000 233,000,000 387,000,000 278,000,000 1,332,000,000 587,000,000 1,387,000,000 332,000,000 480,000,000 497,000,000 392,000,000 887,000,000 748,000,000 269,000,000 102,000,000 
      adjustments to reconcile net income to net cash flows from operating activities:
    		                       
      contract assets
    		                       
      other current assets
    		                       
      contract liabilities
    		                       
      kidde-fenwal, inc. deconsolidation
    		       0 0               
      contract assets, current
    		      -33,000,000 167,000,000 -34,000,000 -12,000,000 -28,000,000 150,000,000 23,000,000 -70,000,000 -154,000,000 19,000,000 -25,000,000 3,000,000 -44,000,000 111,000,000 20,000,000 -101,000,000 -39,000,000 
      other assets, current
    		      -52,000,000 -42,000,000 30,000,000 -45,000,000 -60,000,000 107,000,000 34,000,000 -22,000,000 -15,000,000 9,000,000 7,000,000 -4,000,000 -23,000,000 -49,000,000 20,000,000 42,000,000 -10,000,000 
      contract liabilities, current
    		      -18,000,000 19,000,000 18,000,000 -27,000,000 64,000,000 -5,000,000 -8,000,000 29,000,000 13,000,000 8,000,000 1,000,000 3,000,000 39,000,000 2,000,000 7,000,000 -14,000,000 51,000,000 
      defined benefit plan contributions
    		      -6,000,000 -16,000,000 -6,000,000 -5,000,000 -6,000,000 -6,000,000 -4,000,000 -2,000,000 -4,000,000 -18,000,000 -2,000,000 -3,000,000 -24,000,000 -12,000,000    
      adjustments to reconcile net income from operations to net cash flows from operating activities
    		                       
      impairment charge on minority-owned joint venture investments
    		               0    0 0   
      proceeds on sale of investments
    		                       
      net transfers to utc
    		                   0 0 589,000,000 -10,948,000,000 
      (gain) loss on sale of investments and businesses
    		                       
      adjustments to reconcile net income from operations to net cash flows from operating activities, net of acquisitions and dispositions
    		                       
      equity compensation cost
    		                       
      gains on sale of investments and businesses
    		                       
      proceeds on sale of investments and businesses
    		                       
      receipt from settlement of derivative contracts
    		                   -27,000,000    
      net cash flows used in financing activities
    		                      -76,000,000 
      stock compensation costs
    		                    21,000,000 22,000,000 13,000,000 
      gain on sale of investment
    		                       
      proceeds on sale of investment
    		                       
      pension contributions
    		                     -2,000,000 -25,000,000 
      (payment) receipt from settlement of derivative contracts
    		                       
      net cash flows used in investing activities
    		                     25,000,000 -128,000,000 
      impairment charge on minority owned joint venture investment
    		                      71,000,000 
      net decrease in cash and cash equivalents and restricted cash
    		                      -185,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.